Slate Path Capital Portfolio holdings
Slate Path Capital runs hedge funds that go long and short on stocks around the world, with sizeable positions in other assets too. The firm was established in 2012 and is owned by David Greenspan and JADES GP, a company in which Greenspan is the principal owner. Its stock picking rests on company research, and it aims for long-term growth adjusted for risk. Its two main funds use significant leverage and concentrated positions, and the firm can also trade digital assets such as Bitcoin and Ethereum. One group of its funds avoids long positions in fossil fuel assets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuitive Surgical
ISRG
|
+$125M |
| 2 |
Allegion
ALLE
|
+$86.8M |
| 3 |
YOKU
YOUKU TUDOU INC.(CAYMAN ISLS)
YOKU
|
+$49.5M |
| 4 |
Cleveland-Cliffs
CLF
|
+$14.5M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
+$11.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Trip.com Group
TCOM
|
+$91.4M |
| 2 |
ENDP
Endo International plc
ENDP
|
+$73.9M |
| 3 |
Cheniere Energy
LNG
|
+$70.3M |
| 4 |
Marathon Petroleum
MPC
|
+$60.6M |
| 5 |
ZNGA
ZYNGA INC. CL A COMMON
ZNGA
|
+$56.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 67.41% |
| 2 | Communication Services | 9.98% |
| 3 | Healthcare | 6.84% |
| 4 | Materials | 3.95% |
| 5 | Financials | 2.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$800B
| $1.78B | 49.78% |
+9,100,000
| New | +$1.73B |
2014 Q2
0 quarters
|
|
|
2
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$800B
| $362M | 10.12% |
+1,850,000
| New | +$352M |
2014 Q2
0 quarters
|
|
3
PUT
Invesco QQQ Trust
QQQ
$461B
| $235M | 6.56% |
+2,500,000
| New | +$223M |
2014 Q2
0 quarters
|
|
4
Charter Communications
CHTR
$15.2B
| $144M | 4.03% |
910,000
-285,000
| -24% | -$39.3M |
2013 Q2
4 quarters
|
|
|
5
Intuitive Surgical
ISRG
$152B
| $129M | 3.61% |
+2,826,000
| New | +$125M |
2014 Q2
0 quarters
|
|
6
Barrick Mining
B
$61.6B
| $129M | 3.59% |
7,027,000
-973,000
| -12% | -$16.9M |
2014 Q1
1 quarter
|
|
7
DELISTED
Pandora Media Inc
P
| $113M | 3.15% |
3,825,000
-1,000,000
| -21% | -$26.1M |
2013 Q3
3 quarters
|
|
8
American International
AIG
$42.8B
| $107M | 2.99% |
1,960,000
-740,000
| -27% | -$39.2M |
2013 Q2
4 quarters
|
|
9
SiriusXM
SIRI
$10.7B
| $100M | 2.8% |
2,894,000
| – | – |
2013 Q2
4 quarters
|
|
|
10
Trip.com Group
TCOM
$27.2B
| $93.8M | 2.62% |
2,930,000
-3,390,000
| -54% | -$91.4M |
2013 Q3
3 quarters
|
|
|
11
Allegion
ALLE
$16.2B
| $93.5M | 2.61% |
+1,650,000
| New | +$86.8M |
2014 Q2
0 quarters
|
|
|
ENDP
12
DELISTED
Endo International plc
ENDP
| $77.7M | 2.17% |
1,110,000
-1,105,000
| -50% | -$73.9M |
2013 Q2
4 quarters
|
|
|
YOKU
13
DELISTED
YOUKU TUDOU INC.(CAYMAN ISLS)
YOKU
| $52.6M | 1.47% |
+2,205,000
| New | +$49.5M |
2014 Q2
0 quarters
|
|
|
14
Marathon Petroleum
MPC
$112B
| $37.9M | 1.06% |
970,000
-1,370,000
| -59% | -$60.6M |
2013 Q4
2 quarters
|
|
15
PBF Energy
PBF
$8.41B
| $37.8M | 1.06% |
1,420,000
| – | – |
2013 Q2
4 quarters
|
|
|
16
Alnylam Pharmaceuticals
ALNY
$21B
| $37.8M | 1.06% |
598,000
+186,460
| +45% | +$11.1M |
2013 Q2
4 quarters
|
|
|
QCOR
17
PUT
DELISTED
QUESTCOR PHARMA INC
QCOR
| $34.2M | 0.96% |
+370,000
| New | +$31.7M |
2014 Q2
0 quarters
|
|
|
18
Cleveland-Cliffs
CLF
$7.46B
| $12.9M | 0.36% |
+855,000
| New | +$14.5M |
2014 Q2
0 quarters
|
|
|
19
Cheniere Energy
LNG
$63.2B
| – | – |
-1,270,000
| Closed | -$70.3M | – |
|
|
ZNGA
20
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| – | – |
-13,121,148
| Closed | -$56.4M | – |
|
|
ARIA
21
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| – | – |
-6,620,000
| Closed | -$53.4M | – |
|
Similar funds
Slate Path Capital's Q2 2014 Portfolio in Review
As of Q2 2014, Slate Path Capital held 21 positions worth $3.58B, up 171% from $1.32B the previous quarter. Its ten largest holdings account for 89% of the portfolio.
Slate Path Capital withdrew a net $241M in Q2 2014, closing 3 positions and reducing 7 holdings. Its most notable exit was Cheniere Energy, an estimated $70.3M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 67% of assets, followed by Communication Services and Healthcare.
Against the trend, Slate Path Capital opened a new position in Intuitive Surgical worth $129M.
- Slate Path Capital's largest Q2 2014 buy was Intuitive Surgical: 2,826,000 shares worth $129M.
- Slate Path Capital added most to Alnylam Pharmaceuticals in Q2 2014, an estimated $11.1M increase.
- Slate Path Capital's biggest Q2 2014 reduction was Trip.com Group, cutting an estimated $91.4M.
- Slate Path Capital fully exited Cheniere Energy in Q2 2014, selling an estimated $70.3M.
- Slate Path Capital's ten largest holdings make up 89% of its $3.58B portfolio in Q2 2014.
- Slate Path Capital opened 8 new positions and closed 3 in Q2 2014.
- Slate Path Capital's portfolio value rose 171% quarter-over-quarter to $3.58B.
Based on Slate Path Capital's 13F filing for Q2 2014, filed 14 Aug 2014.